During the morning session, Applied UV moved 57.7%, compared to 0.1% for the S&P 500.
Applied UV, Inc., through its subsidiaries, develops, acquires, and commercializes technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States, Canada, and Europe. Based in Mount Vernon, the company has 61 full time employees and a market cap of $21,020,207.
The company is now trading -67.2% away from its average analyst target price of $5 per share. The 2 analysts following the stock have set target prices ranging from $2 to $8, and on average give Applied UV a rating of buy.
Over the last year, AUVI shares have gone down by -40.2%, which represents a difference of -31.8% when compared to the S&P 500. The stock's 52 week high is $4.2 per share and its 52 week low is $0.83. Based on Applied UV's average gross margin growth of 24.5% over the last four years, its core business remains strong. However prospective investors should keep an eye on the company's negative cash flows.
| 2019-12-31 | 2020-12-31 | 2021-12-31 | |
|---|---|---|---|
| Revenue (k) | $9,330 | $5,733 | $11,668 |
| Revenue Growth | n/a | -38.55% | 103.53% |
| Gross Margins | 35.6% | 17.6% | 35.1% |
| Gross Margins Growth | n/a | -50.56% | 99.43% |
| Operating Margins | 15.0% | -57.8% | -62.5% |
| Operating Margins Growth | n/a | -485.33% | -8.13% |
| Earnings Per Share | $0.44 | -$0.59 | -$0.86 |
| EPS Growth | n/a | -234.09% | -45.76% |
| Free Cash Flow (k) | $757 | -$876 | -$7,027 |
| FCF Growth | n/a | -215.66% | -702.31% |
| Capital Expenditures (k) | -$13 | -$219 | -$29 |
| LT Debt to Equity | 0.09 | 0.03 | 0.0 |
